Efficacy, effectiveness and side effects of medications used to prevent fractures. - Test2 - elhamkhani - TriplyDB

Efficacy, effectiveness and side effects of medications used to prevent fractures.

Efficacy, effectiveness and side effects of medications used to prevent fractures.

http://www.wikidata.org/entity/Q41704607

about

Long-term Effects of Antihypertensive Drug Use and New-onset Osteoporotic Fracture in Elderly Patients: A Population-based Longitudinal Cohort Study Osteoporosis management in residential care: How internal and family medicine resident physicians translate evidence into practice Odanacatib: an emerging novel treatment alternative for postmenopausal osteoporosis.Short Anabolic Peptides for Bone Growth.Disparities in osteoporosis treatments.Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures.Effect of Strontium Ranelate on the Muscle and Vertebrae of Ovariectomized Rats.Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea.Effect of a single intravenous zoledronic acid administration on biomarkers of acute kidney injury (AKI) in patients with osteoporosis: a pilot study.The Potential of Probiotics as a Therapy for Osteoporosis.[Current prevention and treatment strategies for osteoporosis. Fracture-oriented, effective, low side effects and inexpensive].La prise en charge de l’ostéoporose en soins de longue durée: Comment les résidents en médecine interne et en médecine familiale appliquent-ils les données probantes dans la pratique.

P2860

Q28468516-F96936DE-2E04-4571-BFB3-3F668E048EA5 Q33675527-AE93F8D8-4C30-449E-A558-7463FBABB5D1 Q38582108-A00F655F-42A1-4216-AA20-23B295C637E5 Q38864194-3151A907-9E34-439F-9031-4326C775F5E4 Q38980554-0488B212-D168-409F-B650-36F36892ECDC Q40621383-044F78FF-371E-42CA-8749-C0E708926954 Q47291611-28A286F7-B4E8-425B-8FAF-EC0C4D3C1BDE Q48210669-9FC432F8-24BA-40EF-86AD-F9BADA2DDB48 Q50623601-7A0828F6-B8FD-4C98-BE41-716423703AEB Q51800938-3019E226-61BB-4377-AC8D-C0F25E87D2AC Q53664984-EF030012-F0BB-49C2-81E0-5BD6B7417AB0 Q54918907-849E0CDF-FDF6-4F36-ADDA-1139BC13F39C

P2860

Efficacy, effectiveness and side effects of medications used to prevent fractures.

http://www.wikidata.org/entity/Q41704607

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Efficacy, effectiveness and side effects of medications used to prevent fractures.

@en

type

label

Efficacy, effectiveness and side effects of medications used to prevent fractures.

@en

prefLabel

Efficacy, effectiveness and side effects of medications used to prevent fractures.

@en

P1433

Q41704607-24791CD0-7BCE-4B0A-89F1-5BC8D4B554D7

P1476

Q41704607-69D62E03-001B-4CBB-9EC3-6BA36124E853

P2093

Q41704607-F1BE1785-C0CF-42E1-9BD9-45EE184E5126

P2860

Q41704607-013912BA-3E70-49E9-8993-E5EB680012C6

Q41704607-0204FA0D-5FCD-4BDE-8C6D-6A9E7D266613

Q41704607-026B84A5-B8FA-4929-A9D9-E6E125CE7037

Q41704607-03C8835A-F6FE-44E7-AF1A-0A955E4E4726

Q41704607-108F673E-54C4-48A4-B4EA-1F0ED9E93E4C

Q41704607-10FBCD42-325B-4BDA-916C-A0D4C7968644

Q41704607-13AA7728-104D-413C-8557-C1A8CDCD6343

Q41704607-1C4B4925-5EAE-41A4-9D6E-7FAF9303204A

Q41704607-1FFB992D-9E5E-473A-B0EB-181AB82BF2AA

Q41704607-224E2466-1A7E-4869-BB9E-5DF8B52D6DF6

P304

Q41704607-479FE59D-ECEF-4BB2-AB26-A61EC1FEEC4F

P31

Q41704607-163551D1-56DA-4211-B7DB-DDF8E117CA7D

P356

Q41704607-2F55299B-003F-456C-BF48-3DFD53322AF2

P407

Q41704607-15EA98CE-C9FE-4C2A-8756-DE577F32D696

P433

Q41704607-B8A282E5-2525-4DB4-9A08-68734A931DED

P478

Q41704607-D8EF0938-D01E-4D1A-A395-C3C7D0957FA4

P50

Q41704607-39F10CB0-95BA-413D-8FC3-1C5C1EF662BE

P577

Q41704607-776D950C-40A6-4EE4-922A-C01DDB55C436

P698

Q41704607-EA9F68F6-4AAA-4527-BED4-B679397B53EC

P356

P1433

Journal of Internal Medicine

P1476

Efficacy, effectiveness and side effects of medications used to prevent fractures

@en

P2093

I R Reid

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Vitamin D receptor in osteoblasts is a negative regulator of bone mass control

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial.

Influence of calcium intake and physical activity on proximal femur bone mass and structure among pre- and postmenopausal women. A 10-year prospective study.

The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program.

P304

690-706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOIM.12339

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25495429

http://www.w3.org/2001/XMLSchema#string